Kaya Limited · NSE:KAYA

Kaya — Q2 FY20 Earnings Presentation

24 slides from Kaya's earnings presentation, Oct 24, 2019

  1. Slide 1: Performance update letter to stock exchanges

    Kaya Limited October 24, 2019 To, BSE Limited National Stock ExchangeofIndia Limited Market Operations Department, "Exchange Plaza’, 5‘ Floor, 1st Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, Dalal Street, Bandra Kurla Complex, Mumbai - 400001 Bandra(E), Mumbai 400051 BSE Scrip Code: 539

  2. Slide 2: Q2 FY20 Investor Update

    Q2 FY20 Investor Update

  3. Slide 3: Disclaimer

    Disclaimer This investor presentation has been prepared by Kaya Limited (“Kaya”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered or supplied should not be d

  4. Slide 4: Key Highlights

    Key Highlights

  5. Slide 5: Highlights Q2 FY20

    Highlights • Group Net Revenue grew by 1% over Q1 FY20. • Kaya India Net Revenue grew by 9% over Q1 FY20. • Product business grew by 16% in Q2FY20 over Highlights Q2FY19. • Improvement in Gross Margin as compared to Q2 FY 20 Q2FY20 by 100 bps. • Improvement of EBITDA Margin to INR 9.5 crs in Q2FY20

  6. Slide 6: Kaya Group - Q2 FY20 Performance

    Kaya Group - Q2 FY20 Performance Collection (INR Crs) Net Revenue (INR Crs) 125 122.1 110 107.6 108 120 106 115 113.9 104 • Collection for Q2FY20 at INR 113.9 crs, declined 101.4 102 by 7% over Q2FY19 110 100 105 98 • Net Revenue (NR) for Q2FY20 at INR 101.4 crs, Q2 FY19 Q2 FY20 Q2 FY19 Q2 FY20 decl

  7. Slide 7: Kaya India – Highlights

    Kaya India – Highlights • Net Revenue for Q2FY20 at INR 53.4 crs, grew by 3% over Q2FY 19, Net Revenue grew by 9% over Q1FY20 • EBITDA is INR 9.5 crs (18% of NR), compared to EBITDA of INR 1.0 crs (2% of NR) in Q2FY19 • PBT at INR (2.8) crs (-5% NR), compared to PBT of INR (1.9) crs (-4% NR) in Q2FY

  8. Slide 8: Kaya India - Clinics NR and Consumption Trend

    Kaya India - Clinics NR and Consumption Trend • Net Revenue grew by 1% over Q2FY19 • Consumption session volume grew by 8% over 49.0 185,000 Q2FY19 47.0 180,000 179,366 45.0 175,000 Rs in crs 43.0 170,000 41.0 165,789 165,000 39.0 37.0 160,000 47.7 48.0 35.0 155,000 Q2 FY 19 Q2 FY 20 Net Revenue Ses

  9. Slide 9: Kaya India Net Revenue

    Kaya India Net Revenue 60 Net Revenue (INR Crs) 54 52 • Kaya India Q2FY20 revenue grew by 3% over Q2FY19 50 41 41 • Service revenue flat over Q2FY19, growth of 15% over 40 Q1FY20 30 • Product revenue grew by 16% over Q2FY19 20 13 11 10 • E Commerce revenue grew by 90% over Q2FY19 - Services Products

  10. Slide 10: Festive communication launched in Mumbai and Delhi

    Festive communication launched in Mumbai and Delhi

  11. Slide 11: Indian States Cities Clinics

    16 Indian States 26 Cities 97 Clinics 700+ Product Retail Outlets

  12. Slide 12: Kaya – Middle East

    Kaya – Middle East Highlights :-  Collection declined by 11% over Q2FY19.  Net Revenue for Q2FY20 at INR 48.0 crs, declined by 14% over Q2FY19.  EBITDA at INR 4.7 crs (10% of NR) as compared to INR 3.3 crs (6% of NR) over Q2FY19.  PAT at INR (4.7) crs (-10% of NR), compared to PAT of INR (2.8) c

  13. Slide 13: Oman Clinics Countries Cities

    Oman 23 Clinics 3 Countries 10 Cities

  14. Slide 14: Financial Highlights : Kaya Group

    Financial Highlights : Kaya Group Particulars (INR crs) Q2 FY20 Q2 FY19 Collection SSG -4% -2% at constant currency 7% Collection 113.9 122.1 Net Revenue SSG flat 6% flat at constant currency Net Revenue 101.4 107.6 EBITDA margin at 14% of NR against 4% of NR LY EBITDA* 14.2 4.3 *EBITDA margin has i

  15. Slide 15: Financial Highlights : India

    Financial Highlights : India Collection SSG at -1% Particulars (INR crs) Q2 FY20 Q2 FY19 Net Revenue SSG at 4% Collection 63.3 65.1 3% EBITDA margin improved to 18% of NR against 2% of NR LY Net Revenue 53.4 52.1 3% *EBITDA margin has improved after considering IND AS 116 adjustment EBITDA* 9.5 1.0

  16. Slide 16: Financial Highlights : Middle East

    Financial Highlights : Middle East Particulars (INR crs) Q2 FY20 Q2 FY19 Collection SSG –ve 7% Collection 50.7 57.0 11% -ve 2% at constant currency Net Revenue 48.0 55.5 14% Net Revenue SSG –ve 4% –ve 4% at constant currency EBITDA 4.7 3.3 *EBITDA margin has improved after considering IND AS 116 adj

  17. Slide 17: Financial Highlights : Q2 FY20

    Financial Highlights : Q2 FY20 Kaya India Kaya Middle East Kaya Group Particulars (Rs in Crs) Q2 FY20 Q2 FY19 Gr % Q2 FY20 Q2 FY19 Gr % Q2 FY20 Q2 FY19 Gr % Collection SSG –ve 4% & Collection 63.3 65.1 -3% 50.7 57.0 -11% 113.9 122.1 -7% -ve 2% at constant currency Net Revenue 53.4 52.1 3% 48.0 55.5

  18. Slide 18: IND AS 116 – Accounting of Lease Rentals

    IND AS 116 – Accounting of Lease Rentals – using Modified Retrospective Approach Impact on Balance Sheet as of 1 April 2019  International Accounting Standard Board issued IFRS 16 INR in crs India Consol which replaces existing IAS 17 for financial projects beginning on or after 1 January 2019. Pro

  19. Slide 19: Corporate Overview

    Corporate Overview

  20. Slide 20: About Kaya

    About Kaya Kaya offers a comprehensive range of skin and hair care Premium Skin and Hair Care services and products brand solutions through a range of  Incorporated in 2003, Kaya is a pioneer in speciality skin & hair care with a Unique Business Model; a blend of Medical + Retail + Hospitality. spe

  21. Slide 21: Our Core Service Categories in Skin Care

    Our Core Service Categories De-Pigmentation Solutions in Skin Care Aqua Therapy, Laser services, Microdermabrasion, Intense Pro Peels, etc. Anti-Ageing Dermal Fillers, Wrinkles Reduction with BOTOX® , Natural Skin Rejuvenation with PRP, Youth Renew Marvel with Thermage, Skin Tightening, Chemical Pee

  22. Slide 22: Solutions in Hair Care

    Entered the Hair Care category in 2016-18 Solutions in Hair Care Consultation + Hair analysis 1 Hair Thinning: Kaya Targeted Root Regen System : Intensive Hair Root Therapy (IHRT), using a diagnostic tool Natural Hair Rejuvenation, Hair Nutri-Infusion Therapy, Hair Root Activation Laser Therapy & 2

  23. Slide 23: Our wide spectrum of Retail Products

    Our wide spectrum of Retail Products Researched and Developed by Kaya’s in-house, expert Dermatologists

  24. Slide 24: Thank You

    Thank You

Kaya — Q2 FY20 Earnings Presentation on 6ix